AxoGen

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
AxoGen
Traded as NASDAQAXGN
Russell 2000 Component
Website www.axogeninc.com/ Edit this on Wikidata

AxoGen is a human tissue company based in Alachua, Florida making products to remedy peripheral nerve damage.[1][2] In 2013 the company raised $18 million in its Initial Public Offering (IPO).[3] AxoGen uses a cell graft technology AVANCE to mimic a human nerve. The company reports recovery in 87 percent of patients with peripheral nerve injuries. AxoGen is part of the Sid Martin Biotechnology Incubator.

See also[edit]

References[edit]

  1. ^ Graft Helps Nerves Regrow; More Patients Avoid Amputation Through Technique Based on Cadaver Implant December 26, 2012 by Melinda Beck
  2. ^ Nerve repair using grafts from cadavers; SURGERY Grafts from cadavers offer alternative, providing more choice, less traumaby Drew Joseph February 19, 2013 San Francisco Chronicle (SFGate)
  3. ^ [Alachua] Business Briefs November 2013 Florida Trend Magazine